WebCindy Buhse Director, Office of Testing and Research . November 1, 2016 . 2 ADF Expectations: • Technologies to impart abuse deterrence ... be forwarded from the FDA laboratory to the product quality reviewer . www.fda.gov Similar wording available in … WebDeputy Director of Operations, Office of Pharmaceutical Quality at FDA. FDA. Feb 2024 - Present2 years. Silver Spring, Maryland, United States.
Cindy Buhse - Deputy Director of Operations, Office of …
WebView Cindy Buhse's email address (c*****@fda***.gov) and phone number. Cindy works at Fda as Deputy Director of Operations, Office of Pharmaceutical Quality at FDA. Cindy is … WebLucinda (Cindy) Buhse is currently the acting Senior Advisor for Scientific Operations in the Office of Pharmaceutical Quality (OPQ) in the Center of Drug Evaluation and Research … cfop 9922
How to Interact and Communicate with FDA on Quality …
WebBuilding on the relationship between Committee E55 and the FDA, the workshop showcased the ongoing work of the committee as well as topic-specific observations from FDA research as related to existing E55 standards. ... (E55 member and workshop panelist); Pallavi Nithyanandan, FDA (E55 member); Cindy Buhse, FDA (workshop panelist); Larry Lee ... WebCindy Buhse 8 . OPRO Structure 9 . OPRO •Mission: OPRO is a customer‐oriented, regulatory‐focused, ... To be the model organization for regulatory and business operations across FDA centers. 10 . Regulatory Business Process Manager (RBPM) •Centralized project managers for: •The Quality Assessment for all applications submitted to CDER WebCindy Buhse (FDA) Nick Cappuccino (IGPA) Jon Clark (FDA) Gérard Damien (EFPIA) Martine Draguet (EFPIA) Nobukazu Igoshi (JPMA) Robert King (FDA) Sabine Kopp (WHO) ... Robert King, FDA –1st Rapporteur and all Q4B members PDG member pharmacopoeias and their continuing support ! Current Members of the ICH Q4B EWG. by67777